• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

来自李-佛美尼综合征家族的p53(+/+)细胞系中的半胱天冬酶激活与异常细胞生长

Caspase Activation and Aberrant Cell Growth in a p53(+/+) Cell Line from a Li-Fraumeni Syndrome Family.

作者信息

Sherif Zaki A

机构信息

Department of Biochemistry and Molecular Biology, Howard University College of Medicine, Howard University, Washington, DC 20059, USA.

出版信息

Genet Res Int. 2015;2015:789201. doi: 10.1155/2015/789201. Epub 2015 Mar 18.

DOI:10.1155/2015/789201
PMID:25866679
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4381654/
Abstract

Wild-type p53 is well known to induce cell cycle arrest and apoptosis to block aberrant cell growth. However, p53's unique role in apoptosis and cell proliferation in Li-Fraumeni Syndrome (LFS) has not been well elucidated. The aim of this study is to characterize the activity of wild-type p53 protein in LFS family dominated by a germline negative mutant p53. As expected, etoposide-treated wild-type p53-containing cell lines, LFS 2852 and control Jurkat, showed a greater rate of caspase- and annexin V-induced apoptotic cell death compared to the p53-mutant LFS 2673 cell line although mitochondrial and nuclear assays could not detect apoptosis in these organelles. The most intriguing part of the observation was the abnormal proliferation rate of the wild-type p53-containing cell line, which grew twice as fast as 2673 and Jurkat cells. This is important because apoptosis inducers acting through the mitochondrial death pathway are emerging as promising drugs against tumors where the role of p53 is not only to target gene regulation but also to block cell proliferation. This study casts a long shadow on the possible dysregulation of p53 mediators that enable cell proliferation. The deregulation of proliferation pathways represents an important anticancer therapeutic strategy for patients with the LFS phenotype.

摘要

众所周知,野生型p53可诱导细胞周期停滞和凋亡,以阻止异常细胞生长。然而,p53在李-弗劳梅尼综合征(LFS)的凋亡和细胞增殖中的独特作用尚未得到充分阐明。本研究的目的是表征在由种系阴性突变型p53主导的LFS家族中野生型p53蛋白的活性。正如预期的那样,与p53突变的LFS 2673细胞系相比,经依托泊苷处理的含有野生型p53的细胞系LFS 2852和对照Jurkat细胞显示出更高的半胱天冬酶和膜联蛋白V诱导的凋亡细胞死亡率,尽管线粒体和细胞核检测未在这些细胞器中检测到凋亡。观察中最引人关注的部分是含有野生型p53的细胞系的异常增殖率,其生长速度是2673和Jurkat细胞的两倍。这一点很重要,因为通过线粒体死亡途径起作用的凋亡诱导剂正在成为对抗肿瘤的有前景的药物,在这些肿瘤中,p53的作用不仅是靶向基因调控,还包括阻止细胞增殖。这项研究对可能导致细胞增殖的p53介质失调投下了长长的阴影。增殖途径的失调代表了针对LFS表型患者的重要抗癌治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a948/4381654/695ea37b098c/GRI2015-789201.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a948/4381654/4abbbf7b28e4/GRI2015-789201.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a948/4381654/c72272896af8/GRI2015-789201.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a948/4381654/fde34dc0374e/GRI2015-789201.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a948/4381654/695ea37b098c/GRI2015-789201.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a948/4381654/4abbbf7b28e4/GRI2015-789201.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a948/4381654/c72272896af8/GRI2015-789201.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a948/4381654/fde34dc0374e/GRI2015-789201.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a948/4381654/695ea37b098c/GRI2015-789201.004.jpg

相似文献

1
Caspase Activation and Aberrant Cell Growth in a p53(+/+) Cell Line from a Li-Fraumeni Syndrome Family.来自李-佛美尼综合征家族的p53(+/+)细胞系中的半胱天冬酶激活与异常细胞生长
Genet Res Int. 2015;2015:789201. doi: 10.1155/2015/789201. Epub 2015 Mar 18.
2
Aberrant p21WAF1-dependent growth arrest as the possible mechanism of abnormal resistance to ultraviolet light cytotoxicity in Li-Fraumeni syndrome fibroblast strains heterozygous for TP53 mutations.异常的p21WAF1依赖性生长停滞作为Li-Fraumeni综合征成纤维细胞株(杂合TP53突变)对紫外线细胞毒性异常抗性的可能机制。
Oncogene. 1998 Aug 6;17(5):533-43. doi: 10.1038/sj.onc.1202271.
3
The role of the p53 tumor suppressor in the response of human cells to photofrin-mediated photodynamic therapy.p53肿瘤抑制因子在人类细胞对卟吩姆钠介导的光动力疗法反应中的作用。
Photochem Photobiol. 2000 Feb;71(2):201-10. doi: 10.1562/0031-8655(2000)071<0201:trotpt>2.0.co;2.
4
Allele-specific wild-type TP53 expression in the unaffected carrier parent of children with Li-Fraumeni syndrome.李-弗劳梅尼综合征患儿未受影响的携带致病基因的亲代中,等位基因特异性野生型TP53的表达
Cancer Genet. 2017 Feb;211:9-17. doi: 10.1016/j.cancergen.2017.01.001. Epub 2017 Jan 9.
5
Characterization of p53 oligomerization domain mutations isolated from Li-Fraumeni and Li-Fraumeni like family members.从李-弗劳梅尼综合征及李-弗劳梅尼综合征样家族成员中分离出的p53寡聚化结构域突变的特征分析。
Oncogene. 1998 Aug 6;17(5):643-9. doi: 10.1038/sj.onc.1201974.
6
Li-Fraumeni Syndrome-Associated Dimer-Forming Mutant p53 Promotes Transactivation-Independent Mitochondrial Cell Death.李-佛美尼综合征相关二聚体形成突变 p53 促进非转录激活依赖性线粒体细胞死亡。
Cancer Discov. 2023 May 4;13(5):1250-1273. doi: 10.1158/2159-8290.CD-22-0882.
7
Li-Fraumeni Syndrome Disease Model: A Platform to Develop Precision Cancer Therapy Targeting Oncogenic p53.李-弗劳梅尼综合征疾病模型:一个开发针对致癌性p53的精准癌症治疗方法的平台。
Trends Pharmacol Sci. 2017 Oct;38(10):908-927. doi: 10.1016/j.tips.2017.07.004. Epub 2017 Aug 14.
8
Association of germline or somatic TP53 missense mutation with oncogene amplification in tumors developed in patients with Li-Fraumeni or Li-Fraumeni-like syndrome.胚系或体细胞 TP53 错义突变与李-佛美尼或李-佛美尼样综合征患者肿瘤中癌基因扩增的关联。
Genes Chromosomes Cancer. 2011 Jul;50(7):535-45. doi: 10.1002/gcc.20878. Epub 2011 Apr 11.
9
p53 and hereditary cancer.p53与遗传性癌症
Subcell Biochem. 2014;85:1-16. doi: 10.1007/978-94-017-9211-0_1.
10
Mechanism of functional inactivation of a Li-Fraumeni syndrome p53 that has a mutation outside of the DNA-binding domain.一种李-佛美尼综合征p53在DNA结合域外发生突变后的功能失活机制。
Cancer Res. 2001 Feb 15;61(4):1741-6.

引用本文的文献

1
Regulation of the expression of tumor necrosis factor‑related genes by abnormal histone H3K27 acetylation: Implications for neural tube defects.异常组蛋白 H3K27 乙酰化对肿瘤坏死因子相关基因表达的调控:对神经管缺陷的影响。
Mol Med Rep. 2018 Jun;17(6):8031-8038. doi: 10.3892/mmr.2018.8900. Epub 2018 Apr 19.
2
The effect of epigenetic silencing and TP53 mutation on the expression of DLL4 in human cancer stem disorder.表观遗传沉默和TP53突变对人类癌症干细胞疾病中DLL4表达的影响。
Oncotarget. 2016 Sep 27;7(39):62976-62988. doi: 10.18632/oncotarget.11316.

本文引用的文献

1
Apoptosis therapy in cancer: the first single-molecule co-activating p53 and the translocator protein in glioblastoma.癌症中的凋亡疗法:首个同时激活胶质母细胞瘤中p53和转位蛋白的单分子药物
Sci Rep. 2014 Apr 23;4:4749. doi: 10.1038/srep04749.
2
Touching base with PARPs: moonlighting in the repair of UV lesions and double-strand breaks.与 PARPs 接触:在修复 UV 损伤和双链断裂方面的兼职活动。
Trends Biochem Sci. 2013 Jun;38(6):321-30. doi: 10.1016/j.tibs.2013.03.002. Epub 2013 Apr 4.
3
Rap2b, a novel p53 target, regulates p53-mediated pro-survival function.
Rap2b,一个新的 p53 靶点,调节 p53 介导的促生存功能。
Cell Cycle. 2013 Apr 15;12(8):1279-91. doi: 10.4161/cc.24364. Epub 2013 Mar 27.
4
Apoptosis therapy: driving cancers down the road to ruin.凋亡疗法:将癌症引向覆灭之路。
Nat Med. 2013 Feb;19(2):131-3. doi: 10.1038/nm.3076.
5
Divergent control of Cav-1 expression in non-cancerous Li-Fraumeni syndrome and human cancer cell lines.非癌症性 Li-Fraumeni 综合征和人类癌细胞系中 Cav-1 表达的差异调控。
Cancer Biol Ther. 2013 Jan;14(1):29-38. doi: 10.4161/cbt.22621. Epub 2012 Oct 31.
6
Balanced t(11;15)(q23;q15) in a TP53+/+ breast cancer patient from a Li-Fraumeni syndrome family.来自李-佛美尼综合征家族的一名TP53基因双拷贝野生型乳腺癌患者中的平衡易位t(11;15)(q23;q15)
Cancer Genet Cytogenet. 2006 Jul 1;168(1):50-8. doi: 10.1016/j.cancergencyto.2005.12.009.
7
Etoposide-induced cytogenotoxicity in mouse spermatogonia and its potential transmission.依托泊苷对小鼠精原细胞的细胞遗传毒性及其潜在传递
J Appl Toxicol. 2005 Mar-Apr;25(2):94-100. doi: 10.1002/jat.1040.
8
TANK2, a new TRF1-associated poly(ADP-ribose) polymerase, causes rapid induction of cell death upon overexpression.TANK2,一种新的与TRF1相关的聚(ADP - 核糖)聚合酶,在过表达时会导致细胞死亡的快速诱导。
J Biol Chem. 2001 Sep 21;276(38):35891-9. doi: 10.1074/jbc.M105968200. Epub 2001 Jul 13.
9
Surfing the p53 network.探索p53网络
Nature. 2000 Nov 16;408(6810):307-10. doi: 10.1038/35042675.
10
Does p53 status influence tumor response to anticancer therapies?p53状态是否会影响肿瘤对抗癌治疗的反应?
Anticancer Drugs. 2000 Jul;11(6):419-32. doi: 10.1097/00001813-200007000-00002.